the sun malaysia ipaper logo 150x150
Saturday, December 13, 2025
21.7 C
Malaysia
the sun malaysia ipaper logo 150x150

FDA plans black box warning for Covid-19 vaccines, reports say

The FDA intends to apply its most serious safety warning to Covid-19 vaccines, citing risks like heart inflammation, according to a CNN report.

THE U.S. Food and Drug Administration intends to put a ‘black box’ warning on Covid-19 vaccines, CNN reported on Friday, citing two people familiar with the agency’s plans.

The ‘black box’ is the most serious type of warning, which highlights major risks such as serious side effects and restrictions.

The plan to install the warnings for Covid shots is being orchestrated by Vinay Prasad, the FDA’s chief medical and scientific officer and director of the agency’s Center for Biologics Evaluation and Research, the report added.

ALSO READ: US FDA investigates potential Covid vaccine deaths under Trump admin

Last month, Prasad told staffers in a memo that Covid shots probably contributed to the deaths of at least 10 children who died of heart inflammation.

Vaccine makers Moderna, Pfizer and Novavax , as well as the U.S. Department of Health and Human Services, did not immediately respond to Reuters’ requests for comments.

The FDA is investigating deaths potentially related to Covid-19 vaccines across multiple age groups as part of a safety review, a HHS spokesperson said on Tuesday.

FDA Commissioner Marty Makary has previously said the agency was looking at such deaths in young people.

Health Secretary Robert F. Kennedy Jr., a long time vaccine skeptic, has sharply changed government policy on Covid vaccines, limiting access to people aged 65 and above, as well as those with underlying conditions.

The plan to add the warning has not been finalized and may still change, CNN reported.

It was not immediately clear whether the plans for the warnings, expected to be unveiled by the end of the year, would be applied only to mRNA vaccines or all Covid vaccines, and if they would apply to all age groups, the report added.

Vaccines from Pfizer and partner BioNTech and Moderna use messenger RNA technology, while Novavax’s shot is a more traditional protein-based one. – Reuters

Related

spot_img

Latest

Ganesh Bangah, 7-Eleven’s Xamble integrates with Lazada to scale regional creator commerce

Xamble Group has integrated its Creator App with Lazada, enabling creators in Malaysia to generate affiliate links, promote products and track commissions within its platform. The move strengthens Xamble’s creator commerce engine, expands earning opportunities for creators and supports the group’s regional social commerce growth strategy across Southeast Asia.

Oasis Harvest to acquire 80% stake in Contagious for RM900,000

Oasis Harvest Corporation Bhd has entered into a conditional agreement to acquire an 80% equity interest in Contagious (Malaysia) Sdn Bhd for RM900,000, strengthening its consumer engagement capabilities. The acquisition, backed by a one-year profit guarantee, supports Oasis Harvest’s strategy to build a broader food and lifestyle ecosystem while enhancing brand experience and marketing execution across its growing F&B portfolio.

Farm’s Best expands national cancer support at iFood Expo

Farm’s Best Food Industries Sdn Bhd has concluded its participation at the iFood Expo Cultural & Food Festival 2025 and is now extending its Omega 3 Chicken CSR Campaign nationwide to support cancer patients and their families. Running until May 2026, the initiative donates RM1 for every RM25 spent on Omega 3 Chicken products, with a fundraising target of RM50,000 to fund patient care, essential needs, early detection, and cancer awareness programmes through its partner cancer society.

Leading institutional investors establish strategic stakes in Orkim following IPO

Orkim Berhad’s listing on the Main Market of Bursa Malaysia marks a significant milestone, reinforcing the coordinated roles of Ekuinas and Permodalan Nasional Berhad in nurturing and stewarding Bumiputera enterprises. Entering the public market with a valuation of RM920 million, the listing was met with strong investor demand and positions Orkim for its next phase of growth.

Most Viewed

The Chamber of Hong Kong Listed Companies Announces Winners of the ‘Hong Kong Corporate Governance and ESG Excellence Awards 2025’

HONG KONG SAR - Media OutReach Newswire - 12 December 2025 -Hong Kong has reclaimed its top position in the global initial public offering (IPO) fundraising rankings this year, reaffirming its strength in attracting international capital and solidifying its status as a global fundraising hub.
spot_img

Popular Categories